Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling

Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodelingLeukemia, Published online: 3 October 2017; doi:10.1038/leu.2017.305

Source: Leukemia - October 3, 2017 Category: Hematology Authors: G Kerdivel V Chesnais E Becht A Toma N Cagnard F Dumont A Rousseau P Fenaux S Chevret N Chapuis V Boeva W H Fridman M Fontenay O Kosmider Source Type: research